Hepatitis B surface antigen clearance rate achieved with pegylated interferon-α therapy (IMAGE)
Caption
This comprehensive systematic meta-analysis revealed that PegIFNα significantly enhances HBsAg clearance in different chronic HBV infection populations, particularly in NAs-treated patients, inactive HBsAg carriers, and children with CHB.
Credit
Prof. Enqiang Chen from West China Hospital, China
Usage Restrictions
Credit must be given to the creator.
License
Original content